CLINICAL_TRIALS
withdrawal
· 2022-08-19
Clinical Trial Update: Peri-Incisional Drug Injection in Lumbar Spine Surgery [Phase 3]
Summary
A Phase 3 trial investigating peri-incisional drug injection in lumbar spine surgery has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Minnesota | Conditions: Lumbar Disc Herniation, Degenerative Disc Disease | Phase 3 | Status: WITHDRAWN